MELISSA SHELLEY: Open Payments
NPI 1548274764 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$989 in 41 payments from 15 companies in 2025. Trend: 2023 $1,089 · 2024 $2,086 · 2025 $989
Food & beverage: $989
| Company | Payments | Amount |
|---|---|---|
| Biosense Webster, Inc. | 4 | $201 |
| Novartis Pharmaceuticals Corporation | 9 | $182 |
| PFIZER INC. | 5 | $112 |
| BIOTRONIK INC. | 4 | $72 |
| CVRx, Inc. | 3 | $71 |
| Amgen Inc. | 3 | $62 |
| Novo Nordisk Inc | 2 | $54 |
| AtriCure, Inc. | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
Products named: CARTO 3, LEQVIO, ELIQUIS, Barostim Neo System, REPATHA, Wegovy, ATRICLIP LAA EXCLUSION SYSTEM, CAMZYOS.
Industry payments across NV — which companies pay providers there.
